Serum Institute has applied for full market authorisation of Covishield: CEO Adar Poonawala - Daily News Indiatimes.com: Trending stories, Latest News, Breaking News, National News, World News

Daily News Indiatimes.com: Trending stories, Latest News, Breaking News, National News, World News

Indiatimes.com brings you the news, articles, stories and videos on entertainment, latest lifestyle, culture & new technologies emerging worldwide.Read the Latest News On Business, Politics, Sports, Entertainment & Much More From India And Around The World At. Comprehensive, up-to-date news coverage, aggregated from sources all over the world by Google News.

Breaking

Home Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Friday, December 31, 2021

Serum Institute has applied for full market authorisation of Covishield: CEO Adar Poonawala

Serum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla informed in a tweet on Friday. Serum Institute, which produces AstraZeneca's Covid-19 vaccine under the brand name Covishield, has supplied more than 1.25 billion doses of the vaccine in India.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3EBiFJS

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages